Equifax (EFX) Competitors

Equifax has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, Charles River Associates has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.4%. Charles River Associates pays an annual dividend of $2.28 per share and has a dividend yield of 1.6%. Equifax pays out 39.4% of its earnings in the form of a dividend. Charles River Associates pays out 31.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has increased its dividend for 1 consecutive years and Charles River Associates has increased its dividend for 7 consecutive years. Charles River Associates is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax currently has a consensus price target of $228.06, indicating a potential upside of 44.54%. Charles River Associates has a consensus price target of $245.00, indicating a potential upside of 76.34%. Given Charles River Associates' higher possible upside, analysts clearly believe Charles River Associates is more favorable than Equifax.

Equifax has a net margin of 11.12% compared to Charles River Associates' net margin of 6.22%. Charles River Associates' return on equity of 26.02% beat Equifax's return on equity.

96.2% of Equifax shares are held by institutional investors. Comparatively, 84.1% of Charles River Associates shares are held by institutional investors. 1.7% of Equifax shares are held by insiders. Comparatively, 4.5% of Charles River Associates shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Equifax had 3 more articles in the media than Charles River Associates. MarketBeat recorded 15 mentions for Equifax and 12 mentions for Charles River Associates. Equifax's average media sentiment score of 0.50 beat Charles River Associates' score of 0.08 indicating that Equifax is being referred to more favorably in the media.

Equifax has higher revenue and earnings than Charles River Associates. Charles River Associates is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

96.2% of Equifax shares are held by institutional investors. Comparatively, 94.2% of Aptiv shares are held by institutional investors. 1.7% of Equifax shares are held by insiders. Comparatively, 0.1% of Aptiv shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Equifax has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, Aptiv has a beta of 1.42, meaning that its stock price is 42% more volatile than the broader market.

Equifax currently has a consensus price target of $228.06, indicating a potential upside of 44.54%. Aptiv has a consensus price target of $84.82, indicating a potential upside of 47.22%. Given Aptiv's stronger consensus rating and higher possible upside, analysts plainly believe Aptiv is more favorable than Equifax.

Equifax has a net margin of 11.12% compared to Aptiv's net margin of 1.77%. Equifax's return on equity of 20.41% beat Aptiv's return on equity.

In the previous week, Equifax had 1 more articles in the media than Aptiv. MarketBeat recorded 15 mentions for Equifax and 14 mentions for Aptiv. Equifax's average media sentiment score of 0.50 beat Aptiv's score of 0.33 indicating that Equifax is being referred to more favorably in the media.

Equifax has higher earnings, but lower revenue than Aptiv. Equifax is trading at a lower price-to-earnings ratio than Aptiv, indicating that it is currently the more affordable of the two stocks.

Equifax has a net margin of 11.12% compared to Genpact's net margin of 11.04%. Genpact's return on equity of 22.70% beat Equifax's return on equity.

In the previous week, Genpact had 12 more articles in the media than Equifax. MarketBeat recorded 27 mentions for Genpact and 15 mentions for Equifax. Equifax's average media sentiment score of 0.50 beat Genpact's score of 0.11 indicating that Equifax is being referred to more favorably in the media.

Equifax has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market. Comparatively, Genpact has a beta of 0.61, suggesting that its share price is 39% less volatile than the broader market.

Equifax currently has a consensus price target of $228.06, indicating a potential upside of 44.54%. Genpact has a consensus price target of $43.29, indicating a potential upside of 49.67%. Given Genpact's higher probable upside, analysts plainly believe Genpact is more favorable than Equifax.

Equifax has higher revenue and earnings than Genpact. Genpact is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

96.2% of Equifax shares are owned by institutional investors. Comparatively, 96.0% of Genpact shares are owned by institutional investors. 1.7% of Equifax shares are owned by insiders. Comparatively, 1.6% of Genpact shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Equifax pays an annual dividend of $2.24 per share and has a dividend yield of 1.4%. Genpact pays an annual dividend of $0.75 per share and has a dividend yield of 2.6%. Equifax pays out 39.4% of its earnings in the form of a dividend. Genpact pays out 23.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Equifax has raised its dividend for 1 consecutive years and Genpact has raised its dividend for 6 consecutive years. Genpact is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Equifax has a net margin of 11.12% compared to IQVIA's net margin of 8.33%. IQVIA's return on equity of 30.50% beat Equifax's return on equity.

In the previous week, IQVIA had 3 more articles in the media than Equifax. MarketBeat recorded 18 mentions for IQVIA and 15 mentions for Equifax. IQVIA's average media sentiment score of 0.98 beat Equifax's score of 0.50 indicating that IQVIA is being referred to more favorably in the media.

IQVIA has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Equifax has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

IQVIA currently has a consensus price target of $225.69, indicating a potential upside of 32.23%. Equifax has a consensus price target of $228.06, indicating a potential upside of 44.54%. Given Equifax's higher possible upside, analysts plainly believe Equifax is more favorable than IQVIA.

IQVIA has higher revenue and earnings than Equifax. IQVIA is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks.

89.6% of IQVIA shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 1.7% of IQVIA shares are held by company insiders. Comparatively, 1.7% of Equifax shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.